title: Chemotherapy resistance of glioblastoma stem cells.
authors.forename: A
authors.initials: A
authors.lastname: Eramo
authors.forename: L
authors.initials: L
authors.lastname: Ricci-Vitiani
authors.forename: A
authors.initials: A
authors.lastname: Zeuner
authors.forename: R
authors.initials: R
authors.lastname: Pallini
authors.forename: F
authors.initials: F
authors.lastname: Lotti
authors.forename: G
authors.initials: G
authors.lastname: Sette
authors.forename: E
authors.initials: E
authors.lastname: Pilozzi
authors.forename: L M
authors.initials: LM
authors.lastname: Larocca
authors.forename: C
authors.initials: C
authors.lastname: Peschle
authors.forename: R
authors.initials: R
authors.lastname: De Maria
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D001932:Brain Neoplasms / Q000188:drug therapy / Q000473:pathology; D002945:Cisplatin / Q000494:pharmacology / Q000627:therapeutic use; D004317:Doxorubicin / Q000494:pharmacology / Q000627:therapeutic use; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005047:Etoposide / Q000494:pharmacology / Q000627:therapeutic use; D005909:Glioblastoma / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D019169:Jurkat Cells; D051379:Mice; D008819:Mice, Nude; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000473:pathology; D013997:Time Factors; D014407:Tumor Cells, Cultured; D023041:Xenograft Model Antitumor Assays
chemical_list: D000970:Antineoplastic Agents; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin